Literature DB >> 30937460

Contributing factors in the development of acute lung injury in a murine double hit model.

Philipp Störmann1, Nils Becker2, Leander Künnemeyer2, Sebastian Wutzler2,3, Jan Tilmann Vollrath2, Thomas Lustenberger2, Frank Hildebrand4, Ingo Marzi2, Borna Relja2.   

Abstract

OBJECTIVES: Blunt chest (thoracic) trauma (TxT) is known to contribute to the development of secondary pulmonary complications. Of these, acute lung injury (ALI) is common especially in multiply injured patients and might not only be due to the direct trauma itself, but seems to be caused by ongoing and multifactorial inflammatory changes. Nevertheless, the exact mechanisms and contributing factors of the development of ALI following blunt chest trauma are still elusive.
METHODS: 60 CL57BL/6N mice sustained either blunt chest trauma combined with laparotomy without further interventions or a double hit (DH) including TxT and cecal ligation puncture (CLP) after 24 h to induce ALI. Animals were killed either 6 or 24 h after the second procedure. Pulmonary expression of inflammatory mediators cxcl1, cxcl5, IL-1β and IL-6, neutrophil infiltration and lung tissue damage using the Lung Injury Score (LIS) were determined.
RESULTS: Next to a moderate increase in other inflammatory mediators, a significant increase in CXCL1, neutrophil infiltration and lung injury was observed early after TxT, which returned to baseline levels after 24 h. DH induced significantly increased gene expression of cxcl1, cxcl5, IL-1β and IL-6 after 6 h, which was followed by the postponed significant increase in the protein expression after 24 h compared to controls. Neutrophil infiltration was significantly enhanced 24 h after DH compared to all other groups, and exerted a slight decline after 24 h. LIS has shown a significant increase after both 6 and 24 h compared to both control groups as well the late TxT group.
CONCLUSION: Early observed lung injury with moderate inflammatory changes after blunt chest trauma recovered quickly, and therefore, may be caused by mechanical lung injury. In contrast, lung injury in the ALI group did not undergo recovery and is closely associated with significant changes of inflammatory mediators. This model may be used for further examinations of contributing factors and therapeutic strategies to prevent ALI.

Entities:  

Keywords:  ALI; CLP; Cytokines; Lung injury; Neutrophils; Thoracic trauma; cxcl

Mesh:

Substances:

Year:  2019        PMID: 30937460     DOI: 10.1007/s00068-019-01121-5

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  54 in total

1.  Protective effect of hypothermia in a blunt thoracic trauma and hemorrhagic shock model.

Authors:  Hüseyin Ulger; Turgut Deniz; Faruk Comu; Canan Agalar; Ucler Kisa; Fatih Agalar
Journal:  Thorac Cardiovasc Surg       Date:  2014-10-31       Impact factor: 1.827

2.  Focus on chest trauma.

Authors:  L P H Leenen
Journal:  Eur J Trauma Emerg Surg       Date:  2017-03-03       Impact factor: 3.693

3.  The Effects of Dexamethasone and L-NAME on Acute Lung Injury in Rats with Lung Contusion.

Authors:  Ahmet Kozan; Nermin Kilic; Hasan Alacam; Ahmet Guzel; Tolga Guvenc; Mehmet Acikgoz
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

4.  The epidemiology of posttraumatic adult respiratory distress syndrome.

Authors:  Timothy O White; Paul J Jenkins; Richard D Smith; Christopher W J Cartlidge; C Michael Robinson
Journal:  J Bone Joint Surg Am       Date:  2004-11       Impact factor: 5.284

5.  FN14 Blockade on Pulmonary Microvascular Endothelial Cells Improves the Outcome of Sepsis-Induced Acute Lung Injury.

Authors:  Yun Zou; Suhong Bao; Fang Wang; Long Guo; Jiali Zhu; Jun Wang; Xiaoming Deng; Jinbao Li
Journal:  Shock       Date:  2018-02       Impact factor: 3.454

Review 6.  Chest injuries - what is new?

Authors:  Marius Keel; Christoph Meier
Journal:  Curr Opin Crit Care       Date:  2007-12       Impact factor: 3.687

Review 7.  Role of biomarkers in acute traumatic lung injury.

Authors:  Philipp Störmann; Thomas Lustenberger; Borna Relja; Ingo Marzi; Sebastian Wutzler
Journal:  Injury       Date:  2017-08-24       Impact factor: 2.586

8.  The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Authors:  Kari Ann Shirey; Wendy Lai; Alison J Scott; Michael Lipsky; Pragnesh Mistry; Lioubov M Pletneva; Christopher L Karp; Jaclyn McAlees; Theresa L Gioannini; Jerrold Weiss; Wilbur H Chen; Robert K Ernst; Daniel P Rossignol; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  Nature       Date:  2013-05-01       Impact factor: 49.962

9.  Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Authors:  Steven M Opal; Pierre-Francois Laterre; Bruno Francois; Steven P LaRosa; Derek C Angus; Jean-Paul Mira; Xavier Wittebole; Thierry Dugernier; Dominique Perrotin; Mark Tidswell; Luis Jauregui; Kenneth Krell; Jan Pachl; Takeshi Takahashi; Claus Peckelsen; Edward Cordasco; Chia-Sheng Chang; Sandra Oeyen; Naoki Aikawa; Tatsuya Maruyama; Roland Schein; Andre C Kalil; Marc Van Nuffelen; Melvyn Lynn; Daniel P Rossignol; Jogadish Gogate; Mary B Roberts; Janice L Wheeler; Jean-Louis Vincent
Journal:  JAMA       Date:  2013-03-20       Impact factor: 56.272

10.  Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo.

Authors:  Sean E Gill; Marta Rohan; Sanjay Mehta
Journal:  Respir Res       Date:  2015-09-16
View more
  8 in total

1.  Potential biomarkers for inflammatory response in acute lung injury.

Authors:  Lanzhi Zheng; Zhuoyi Zhang; Kang Song; Xiaoyang Xu; Yixin Tong; Jinling Wei; Lu Jiang
Journal:  Open Med (Wars)       Date:  2022-06-08

Review 2.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

3.  Endogenous Uteroglobin as Intrinsic Anti-inflammatory Signal Modulates Monocyte and Macrophage Subsets Distribution Upon Sepsis Induced Lung Injury.

Authors:  Andrea Janicova; Nils Becker; Baolin Xu; Sebastian Wutzler; Jan Tilmann Vollrath; Frank Hildebrand; Sabrina Ehnert; Ingo Marzi; Philipp Störmann; Borna Relja
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

4.  Club Cell Protein 16 Attenuates CD16brightCD62dim Immunosuppressive Neutrophils in Damaged Tissue upon Posttraumatic Sepsis-Induced Lung Injury.

Authors:  Nils Becker; Philipp Störmann; Andrea Janicova; Kernt Köhler; Klemens Horst; Ildiko Rita Dunay; Claudia Neunaber; Ingo Marzi; Jan Tilmann Vollrath; Borna Relja
Journal:  J Immunol Res       Date:  2021-01-28       Impact factor: 4.818

Review 5.  A nationwide fluidics biobank of polytraumatized patients: implemented by the Network "Trauma Research" (NTF) as an expansion to the TraumaRegister DGU® of the German Trauma Society (DGU).

Authors:  Borna Relja; Markus Huber-Lang; Martijn van Griensven; Frank Hildebrand; Marc Maegele; Ulrike Nienaber; Daniel P Brucker; Ramona Sturm; Ingo Marzi
Journal:  Eur J Trauma Emerg Surg       Date:  2019-07-19       Impact factor: 3.693

6.  Focus on chest trauma: implications from clinical and experimental studies.

Authors:  Klemens Horst; Frank Hildebrand
Journal:  Eur J Trauma Emerg Surg       Date:  2020-02       Impact factor: 3.693

7.  Different experimental multiple trauma models induce comparable inflammation and organ injury.

Authors:  Borna Relja; Bing Yang; Katrin Bundkirchen; Baolin Xu; Kernt Köhler; Claudia Neunaber
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

8.  Early local neutralization of CC16 in sepsis‑induced ALI following blunt chest trauma leads to delayed mortality without benefitting overall survival.

Authors:  Jan Tilmann Vollrath; Philipp Stoermann; Nils Becker; Sebastian Wutzler; Frank Hildebrand; Ingo Marzi; Borna Relja
Journal:  Int J Mol Med       Date:  2020-10-22       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.